Malaria, a worldwide disease of high morbidity and mortality, causes over 1 million deaths per year, mostlyin children less than 5 years of age. Delayed treatment of malaria increases the chances of death and neurological disease. In addition, to bring about malaria eradication and prolong accumulation of drug resistant parasites, treatment must follow an accurate diagnosis. To that end, a major goal in malaria diagnostics is to develop assays that are both sensitive and cost-effective for use in developing countries, which are economically and infrastructurally challenged. This review analyzes the current state of malarial diagnostics, from the gold standard of Giemsa-stained blood smears for microscopic examination to highly sensitive and novel technologies. Here, we suggest a future direction for malarial diagnostics.
Malaria Diagnostics, Where are we Now- Johanna Porter-Kelley
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals. Journal of Tropical Diseases & Public Heath is one of the top journals which publish quality articles, findings dealing with tropical diseases related to human health.
Last date updated on December, 2020